DANIEL SNYDER: Open Payments
NPI 1205240041 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$939 in 47 payments from 10 companies in 2025. Trend: 2023 $18 · 2024 $660 · 2025 $939
Food & beverage: $939
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $435 |
| Novo Nordisk Inc | 7 | $155 |
| ABBVIE INC. | 6 | $93 |
| Lilly USA, LLC | 4 | $80 |
| Phathom Pharmaceuticals, Inc. | 4 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| PFIZER INC. | 2 | $32 |
| Exact Sciences Corporation | 2 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: AIRSUPRA, BREZTRI, Ozempic, MOUNJARO, QULIPTA, FARXIGA, VOQUEZNA, Kerendia.
Industry payments across TN — which companies pay providers there.
